Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,196 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07562659 | Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer(CLEAR-01) | recruiting | Phase 2 | 80 | Fudan UniversityOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07562711 | Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer(CLEAR-02) | recruiting | Phase 2 | 340 | Fudan UniversityOTHER | 1 |
| May 1, 2026 |
| clinicaltrials |
| NCT07451795 | SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC(SHARP) | recruiting | Phase 2 | 66 | Fudan UniversityOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT06613633 | Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC | completed | — | 4,000 | Fudan UniversityOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT07555678 | Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer:Chase(Chase) | recruiting | Phase 2 | 241 | Fudan UniversityOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT02633514 | Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma | withdrawn | Phase 3 | 0 | Fudan UniversityOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT06402708 | Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) | recruiting | Phase 3 | 172 | Fudan UniversityOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT06572722 | Perioperative Immunotherapy for NSCLC (ECTOP-1030) | withdrawn | Phase 2 | 0 | Fudan UniversityOTHER | 0 | Apr 27, 2026 | clinicaltrials |
| NCT02633553 | Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection | recruiting | N/A | 238 | Fudan UniversityOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT06401447 | TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma | active not recruiting | N/A | 50 | Fudan UniversityOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT07551050 | Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer | recruiting | — | 300 | Fudan UniversityOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT07551479 | SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer(TORCH-STAR) | not yet recruiting | Phase 3 | 612 | Fudan UniversityOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT05407155 | Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung Cancer(BETTER) | active not recruiting | N/A | 56 | Fudan UniversityOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT07544784 | AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)(APSOC) | recruiting | Phase 2 | 73 | Fudan UniversityOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT07545720 | Pinoxin for the Prevention of Radiation-Induced Skin Injury | recruiting | Phase 2 | 202 | Fudan UniversityOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT06860490 | HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03) | recruiting | Phase 2 | 164 | Fudan UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07147101 | Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment(HCC-IM-1) | recruiting | — | 150 | Fudan UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07328009 | A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma(HCC-SIGHT) | recruiting | Phase 2 | 350 | Fudan UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07536789 | Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma | recruiting | Phase 2 | 40 | Fudan UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07541664 | Digital Mind-Body Therapy for Neoadjuvant Breast Cancer | recruiting | N/A | 66 | Fudan UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT06964568 | CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC | recruiting | Phase 3 | 452 | Fudan UniversityOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07537205 | The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol | enrolling by invitation | N/A | 92 | Fudan UniversityOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT05749588 | FUSCC Refractory TNBC Platform Study (FUTURE2.0) | recruiting | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT07533357 | Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma | not yet recruiting | — | 158 | Fudan UniversityOTHER | 0 | Apr 16, 2026 | clinicaltrials |
| NCT07527520 | Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial | not yet recruiting | Phase 2 | 165 | Fudan UniversityOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT06314334 | Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma | recruiting | Phase 2 | 210 | Fudan UniversityOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT07517107 | Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer | recruiting | Phase 2 | 600 | Fudan UniversityOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT07514793 | Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma | not yet recruiting | Phase 2 | 37 | Fudan UniversityOTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT07515625 | Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma | not yet recruiting | Phase 2 | 46 | Fudan UniversityOTHER | 0 | Apr 7, 2026 | clinicaltrials |
| NCT06281405 | CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer(TORCH-iTNT) | recruiting | Phase 2 | 192 | Fudan UniversityOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT07509515 | QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC. | not yet recruiting | Phase 2 | 60 | Fudan UniversityOTHER | 0 | Apr 3, 2026 | clinicaltrials |
| NCT04512534 | Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma(Sincerely20) | recruiting | Phase 2 | 51 | Fudan UniversityOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05257018 | R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse | recruiting | Phase 2 | 83 | Fudan UniversityOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05587543 | Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma | recruiting | Early Phase 1 | 24 | Fudan UniversityOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05673577 | Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients | completed | Phase 2 | 41 | Fudan UniversityOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05924256 | A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing | active not recruiting | Phase 2 | 88 | Fudan UniversityOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT06682117 | A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor(Neo-DCV-001) | recruiting | N/A | 9 | Fudan UniversityOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT07507916 | Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma | not yet recruiting | Phase 2 | 32 | Fudan UniversityOTHER | 0 | Apr 2, 2026 | clinicaltrials |
| NCT07300514 | Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma(T-START-M1) | recruiting | Phase 3 | 136 | Fudan UniversityOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07503639 | Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer | not yet recruiting | Phase 2 | 134 | Fudan UniversityOTHER | 0 | Mar 31, 2026 | clinicaltrials |
| NCT07491211 | Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases | active not recruiting | — | 300 | Fudan UniversityOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT05806060 | Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer(BCTOP-T-M01) | recruiting | Phase 3 | 134 | Fudan UniversityOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT05847855 | Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors | recruiting | — | 1,000 | Fudan UniversityOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT06668519 | Magnetoencephalography in Children | recruiting | — | 1,500 | Children's Hospital of Fudan UniversityOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT07492615 | A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma | recruiting | Phase 2 | 276 | Fudan UniversityOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT06519526 | Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma | recruiting | Phase 2 | 25 | Fudan UniversityOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT07006012 | RGL-305+ Lymphoma + Exploratory Clinical Study | recruiting | N/A | 12 | Fudan UniversityOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT07270861 | Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study | recruiting | — | 3,000 | Fudan UniversityOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT07490119 | Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer | not yet recruiting | Phase 2 | 31 | Fudan UniversityOTHER | 0 | Mar 24, 2026 | clinicaltrials |
| NCT07490210 | Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer(OMPC-RPM) | not yet recruiting | Phase 2 | 300 | Fudan UniversityOTHER | 1 | Mar 24, 2026 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials